This article is more than 5 years old. Information may no longer be current.

Report predicts growth in HA viscosupplementation market

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

A new report by Millennium Research Group forecasts “moderate” growth in the global market for hyaluronic acid viscosupplementation to nearly $2.5 billion by 2017 and points to increases in patients with osteoarthritis and obesity as a factor of this growth.

According to a press release from the group, projected market trends will include more “premium-priced shorter treatments” of one- and three-injections and use of hyaluronic acid (HA) viscosupplementation for joints other than the knee.

Companies with competitive pricing, those that develop HA viscosupplementation specifically for areas other than the knee or companies that create single-injection products could see the most success in the market during the period, according to the report.

“Despite the diverse competitive landscape for these products, two companies have captured over half the global market,” Kristina Vidug, an analyst for Millennium Research Group, stated in a press release.

Reference:

www.mrg.net.